Horizon and Rutgers Uni form gene editing partnership
Horizon Discovery and Rutgers University signed a partnership deal to commercialise a new gene editing technology.
Read More
Tag: gene editing
Gilead, Precision to co-develop hepatitis B therapies
Gilead and Precision BioSciences are to work together on developing gene-editing treatments against hepatitis B.
Read More
UK panel says human embryo editing ‘morally permissible’
An independent ethics panel in the UK has concluded that genome editing to influence the characteristics of a future person could be “morally permissible”.
Read More
MHRA authorises in vivo genome editing trial
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted permission for initiation of Europe’s first in vivo genome editing study.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
